XML 71 R66.htm IDEA: XBRL DOCUMENT v2.4.0.6
SEGMENT INFORMATION (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Apr. 30, 2012
Apr. 30, 2011
Apr. 30, 2012
Apr. 30, 2011
SALES:        
Net sales $ 657,976 $ 653,792 $ 1,949,285 $ 1,798,479
SEGMENT PROFIT:        
Segment profit 114,817 126,085 364,386 347,923
Operating profit 98,420 109,631 314,610 302,168
ROTC 2,861 7,723 31,001 13,921
Interest expense, net 6,351 6,068 17,682 19,176
Earnings from continuing operations before income taxes 89,208 95,840 265,927 269,071
Life Sciences [Member]
       
SALES:        
Net sales 317,969 312,691 918,954 852,463
SEGMENT PROFIT:        
Segment profit 75,386 78,885 233,191 213,667
Industrial [Member]
       
SALES:        
Net sales 340,007 341,101 1,030,331 946,016
SEGMENT PROFIT:        
Segment profit 39,431 47,200 131,195 134,256
Corporate Services Group [Member]
       
SEGMENT PROFIT:        
Segment profit $ 16,397 $ 16,454 $ 49,776 $ 45,755